CLINICAL_TRIALS
trial_result
· 2024-05-08
Clinical Trial Update: Everolimus for Children With Recurrent or Progressive Ependymoma [Phase 2]
Summary
Everolimus was studied in a Phase 2 trial for children with recurrent or progressive ependymoma. The study is completed and results were posted in May 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Recurrent Childhood Ependymoma | Phase 2 | Status: COMPLETED | Results posted: 2024-05-08